Efficacy and Safety of Immune Checkpoint Therapy in Hepatocellular Carcinoma: Meta-Analysis

Hepatoma Research
doi 10.20517/2394-5079.2019.07
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

P3.04-18 the Efficacy and Safety of Solid Tumors Combination Therapy With Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis

Cancers
Cancer ResearchOncology
2019English

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and the ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Cancers
Cancer ResearchOncology
2019English

Efficacy and Safety of Thalidomide in Patients With Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2006English

Safety and Efficacy of Concurrent Immune Checkpoint Inhibitors and Hypofractionated Body Radiotherapy

OncoImmunology
OncologyAllergyImmunology
2018English

Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Impact of Patient’s Age on Efficacy of Immune Checkpoint Inhibitors in Advanced Cancers: A Systematic Review and Meta-Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Meta-Analysis of DNA Methylation Biomarkers in Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy